Mrs. Roseline A. Oputa has retired from the Board of Neimeth International Pharmaceuticals Plc.
Pharm. (Mrs.) Oputa joined the Company in 1992 and served in various capacities such as: Manager Sales Training and Customer Satisfaction, National Demand Manager, Group Product Manager, Marketing Manager, Associate Director/Head of Ethical Product Group (EPG), Director of Administration and Corporate Programmes before joining the Board in October 2017 as an Executive Director.
Prior to her retirement Pharm. (Mrs.) Oputa was the Executive Director, Sales & Marketing.
About Neimeth Pharmaceuticals
Neimeth International Pharmaceuticals Plc is a publicly listed Nigerian pharmaceutical company headquartered in Lagos with roots dating back to 1957 when it operated as Pfizer Products Nigeria.
The current entity was formed in 1997 following a management buy-out of Pfizer’s Nigerian business as part of Pfizer Inc.’s global repositioning, and was renamed in honour of a supportive Pfizer executive.
Neimeth specialises in the manufacturing, marketing, and distribution of a broad portfolio of pharmaceutical and animal health products. Its portfolio encompasses ethical prescription medicines, over-the-counter (OTC) healthcare products, and veterinary formulations, with notable brands including Ciklavit, an herbal-based remedy for sickle-cell crisis management, as well as analgesics, antimalarials, antibiotics, nutritional supplements, and antiseptics.
